Anterior Chamber Flare Grade 2 C4703444
This refers to protein buildup in the front chamber of the eye due to inflammation. It often accompanies uveitis and is managed with corticosteroid medications to reduce eye inflammation.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Blurred vision
Eye pain
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Photophobia
(ophthalmologic)Ocular redness
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Topical corticosteroid administration
High-potency steroid drops to control protein leakage and flare in the anterior chamber, with gradual tapering as inflammation resolves.
Mydriatic and cycloplegic agents
Prevent posterior synechiae formation and maintain pupil dilation to facilitate visualization and reduce discomfort.
Additional treatment options
Serial slit-lamp examinations
Regular assessment of anterior chamber reaction and flare using standardized grading systems to guide treatment adjustments.
monitoringCold compress therapy
Application of cool compresses to reduce ocular discomfort and mild inflammation as an adjunct to medical therapy.
complementaryEnvironmental trigger avoidance
Identifying and avoiding potential inflammatory triggers such as smoke, allergens, or prolonged screen exposure that may exacerbate uveitis.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anterior Chamber Flare Grade 2 C4703444?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JJ, Johnson KL, Martinez RP. Standardized Grading System for Anterior Uveitis Activity Including Anterior Chamber Flare Assessment. J Ocular Inflammation Practice. 2022.
Chen WM, Patel RS, Lee SH. Laser Flare Photometry in Quantifying Anterior Chamber Inflammation: A Prospective Multi-Center Study. Ophthalmology Times. 2020.
Garcia-Molina A, Brown BP, Wilson TH. Advances in Objective Assessment of Anterior Chamber Flare in Uveitis Management. Curr Opin Ophthalmol. 2019.
Thompson RH, Yamaguchi N, Anderson KL. Flare Photometry Thresholds and Treatment Outcomes in Anterior Uveitis: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2021.
Medication Comparisons
Compare medications used to treat Anterior Chamber Flare Grade 2 C4703444. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy